Oorsprong van het eerstegraads netwerk van Hong Ying Liu
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hong Ying Liu via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| STAAR SURGICAL COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
China Life Sciences Access Fund LP
 China Life Sciences Access Fund LP Investment ManagersFinance China Life Sciences Access Fund LP is a venture capital fund that operates in the life sciences industry. The private company is based in George Town, Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| TOM GROUP LIMITED | Publishing: Newspapers | General Counsel | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Sullivan & Cromwell LLP
 Sullivan & Cromwell LLP Miscellaneous Commercial ServicesCommercial Services Sullivan & Cromwell LLP provides legal services. It specializes in the areas of corporate law, securities, corporate, litigation, mergers, real estate, pro bono, investment management and taxation. Their clients include industrial, commercial, financial, private funds, governmental, educational, charitable and cultural enterprises and entities. The company was founded by Algernon Sydney Sullivan and William Nelson Cromwell in 1879 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
China Taiping Insurance Group Ltd.
 China Taiping Insurance Group Ltd. Multi-Line InsuranceFinance China Taiping Insurance Group Ltd. engages in the provision of financial and insurance services. Its products and services include life, general, and pension insurance, reinsurance, asset management, securities broking and investment, financial leasing, non-financial investment, and financial support services. The company was founded on November 20, 1929 and is headquartered in Beijing, China. | Multi-Line Insurance | Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Masters Business Admin | |
| The University of New South Wales | College/University | Graduate Degree | |
| The Chinese University of Hong Kong | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
Goldman Sachs (Asia) LLC
 Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Goldman Sachs (Asia) LLC (GS-Asia) is the Hong Kong-based brokerage subsidiary of Goldman Sachs Holdings (Hong Kong) Ltd., ultimately owned by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in New York City. Founded in 1984, GS-Asia provides market insight, risk management and execution services to institutional clients which includes asset managers, hedge funds, banks and brokerages, pensions, endowments and foundations, corporations, and governments. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| Shanghai Institute of Pharmaceutical Industry | College/University | Graduate Degree | |
| East China University of Political Science & Law | College/University | Undergraduate Degree | |
Morgan Stanley Asia Ltd.
 Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Hong Kong Metropolitan University | College/University | Graduate Degree | |
| Yantai University | College/University | Undergraduate Degree | |
| Santen Pharmaceutical (China) Co. Ltd. | Chief Executive Officer Chief Tech/Sci/R&D Officer Sales & Marketing | ||
Neusoft Medical Systems Co., Ltd.
 Neusoft Medical Systems Co., Ltd. Medical SpecialtiesHealth Technology Neusoft Medical Systems Co., Ltd. engages in the research, development, manufacturing, and sale of large-scale medical diagnosis and treatment equipment and solutions as well as the provision of related services. Its products include computed tomography systems, magnetic resonance imaging systems, digital subtraction angiography systems, ultrasonic diagnostic equipment, positron emission tomography equipment, radiotherapy products, as well as in vitro diagnostic equipment and reagents. The company was founded on March 6, 1998 and is headquartered in Shenyang, China. | Medical Specialties | Director/Board Member | |
Peking Union Medical College Hospital
 Peking Union Medical College Hospital Other Consumer ServicesConsumer Services Peking Union Medical College Hospital is a clinical college of Peking Union Medical College in Beijing, CN. It is also a clinical medical research institute of the Chinese Academy of Medical Sciences and one of the national centers for the diagnosis and treatment of difficult and complicated diseases designated by the Ministry of Health. The hospital is well-known for its comprehensive advantages in multiple disciplines, with a complete range of disciplines, strong technical strength, and comprehensive development in medical, teaching, research, and management. | Other Consumer Services | Corporate Officer/Principal | |
| SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| SHANGHAI XNG HOLDINGS LIMITED | Restaurants | Director/Board Member | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Director/Board Member | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Private Equity Investor Chief Executive Officer | |
| NEUSOFT XIKANG HOLDINGS INC. | Data Processing Services | Director/Board Member | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. Pharmaceuticals: GenericHealth Technology TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China. | Pharmaceuticals: Generic | Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sony Music Entertainment China Holdings Ltd.
 Sony Music Entertainment China Holdings Ltd. Financial ConglomeratesFinance Part of Sony Group Corp., Sony Music Entertainment China Holdings Ltd. functions as an investment holding Chinese company. The company is based in Beijing, China. | Financial Conglomerates | Corporate Officer/Principal | |
Institute of Certified Management Accountants (Hong Kong)
 Institute of Certified Management Accountants (Hong Kong) Financial ConglomeratesFinance The Institute of Certified Management Accountants (Hong Kong) functions as an investment holding Chinese company. The private company is based in Hong Kong, Hong Kong. | Financial Conglomerates | Director/Board Member | |
Engine Biosciences Pte Ltd.
 Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Tongrun Biomedicine (Shanghai) Co., Ltd.
 Tongrun Biomedicine (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Tongrun Biomedicine (Shanghai) Co., Ltd. develops tumor immunotherapy drugs. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chairman | |
| 111, INC. | Medical Distributors | Director/Board Member | |
Biotheus, Inc.
 Biotheus, Inc. BiotechnologyHealth Technology Biotheus, Inc. is a biopharmaceutical company based in Zhuhai, China. The Chinese company aims to become a leading domestic biopharmaceutical company with a high-value product chain, strong innovation capabilities, and an experienced core team. It was founded in 2018 by Jun Wei Zeng, Xiao Lin Liu, and Zuo Yu Sun, with Xiao Lin Liu serving as the CEO. | Biotechnology | Director/Board Member | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member | ||
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Director/Board Member | |
| FIL Capital Management (Hong Kong) Ltd. | Corporate Officer/Principal | ||
| Shanghai Hengrui Pharmaceutical Co., Ltd. | Corporate Officer/Principal | ||
| WUXI XDC CAYMAN INC. | Miscellaneous Commercial Services | Director/Board Member | |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Pharmaceuticals: Major | Chairman | |
| CUTIA THERAPEUTICS | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| China | 25 |
| Hongkong | 10 |
| Kaaimaneilanden | 8 |
| Verenigde Staten | 7 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 10 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 81 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 21 |
| Chairman | 18 |
| Undergraduate Degree | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| Ting Yuk Wu | 42 |
| Wei Li | 24 |
| Lian Yong Chen | 24 |
| Yan Ling Cao | 21 |
| Zhen Yu Zhang | 11 |
| Dong Hong Chen | 8 |
| Ye Liu | 7 |
| Tim Ruan | 7 |
| Qinglei Zuo | 6 |
| Yumeng Wang | 5 |
| Yi Ran Huang | 5 |
| Zhao Peng Hu | 4 |
| Ting Chan Chen | 4 |
- Beurs
- Insiders
- Hong Ying Liu
- Bedrijfsconnecties
